Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNF blocker treatment and cardiac function in rheumatoid arthritis
NL-OMON46382Not yet recruiting
- Sponsor
- Overige Centra
- Start
- Jan 2018
- Countries
- 1
01
Overview
Open-label, single-arm trial in rheumatoid arthritis (RA), sponsored by Overige Centra. Primary endpoints: Diastolic left ventricular dysfunction and Rheumatoid arthritis disease activity. Planned start Jan 2018; status: not yet recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON46382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46382.